help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naeije, R.
Right arrow Articles by Delcroix, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naeije, R.
Right arrow Articles by Delcroix, M.

Am. J. Respir. Crit. Care Med., Vol 151, No. 3, 03 1995, 692-697.

Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs

R Naeije, P Wauthy, M Maggiorini, M Leeman and M Delcroix
Laboratory of Cardiovascular and Respiratory Physiology, Erasme University Hospital, Brussels, Belgium.

There has been suggestion of a possible relationship between the intake of the appetite suppressant dexfenfluramine and the development of primary pulmonary hypertension. We investigated the pulmonary vascular effects of acute intravenous dexfenfluramine in pentobarbital- anesthetized dogs ventilated in hyperoxia (fraction of inspired oxygen, FIO2, 0.4) and either challenged with a FIO2 of 0.1 to induce hypoxic pulmonary hypertension (n = 20) or given autologous blood clots to induce embolic pulmonary hypertension (n = 6). Pulmonary vascular tone was evaluated by multipoint (mean pulmonary artery pressure [Ppa] - pulmonary artery occluded pressure [Ppao])/cardiac output (Q) plots. Hypoxia increased Ppa - Ppao over the entire range of Q studied, from 1.5 to 4.0 L/min/m2, in 12 dogs (responders) and had no significant effect on (Ppa - Ppao)/Q plots in 8 other dogs (nonresponders). Dexfenfluramine did not affect (Ppa - Ppao)/Q plots in 6 responders but shifted (Ppa - Ppao)/Q plots to higher pressures in hypoxia in 6 nonresponders (p < 0.001). Dexfenfluramine had no effect on (Ppa - Ppao)/Q plots in the 6 dogs with embolic pulmonary hypertension. Because dexfenfluramine has serotoninergic properties, we compared the effects of ketanserin, a serotonin (5-hydroxytryptamine, 5-HT) S2 receptor antagonist, on naturally present versus dexfenfluramine- restored hypoxic pulmonary vasoconstriction. Ketanserin did not affect hyperoxic or hypoxic pulmonary vascular tone, neither in 6 responders nor in 2 nonresponders with dexfenfluramine-restored hypoxic vasoconstriction. We conclude that dexfenfluramine restores hypoxic pulmonary vasoconstriction in dogs with weak or absent hypoxic pressor response and that this effect is unlikely to be mediated by activation of 5-HT S2 receptors.


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. A. Caccitolo, H. M. Connolly, D. S. Rubenson, T. A. Orszulak, and H. V. Schaff
Operation for anorexigen-associated valvular heart disease
J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 656 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. L. ARCHER, K. DJABALLAH, M. HUMBERT, E. KENNETH WEIR, M. FARTOUKH, J. DALL'AVA-SANTUCCI, J.-C. MERCIER, G. SIMONNEAU, and A. TUAN DINH-XUAN
Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1061 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. EDDAHIBI, B. RAFFESTIN, J.-M. LAUNAY, M. SITBON, and S. ADNOT
Effect of Dexfenfluramine Treatment in Rats Exposed to Acute and Chronic Hypoxia
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1111 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. K. Weir, H. L. Reeve, J. M.C. Huang, E. Michelakis, D. P. Nelson, V. Hampl, and S. L. Archer
Anorexic Agents Aminorex, Fenfluramine, and Dexfenfluramine Inhibit Potassium Current in Rat Pulmonary Vascular Smooth Muscle and Cause Pulmonary Vasoconstriction
Circulation, November 1, 1996; 94(9): 2216 - 2220.
[Abstract] [Full Text]

Home page
 NEJMHome page
L. Abenhaim, Y. Moride, F. Brenot, S. Rich, J. Benichou, X. Kurz, T. Higenbottam, C. Oakley, E. Wouters, M. Aubier, et al.
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
N. Engl. J. Med., August 29, 1996; 335(9): 609 - 616.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society